Efficacy and Safety of Ruxolitinib and Steroids for Treating Patients with Relapsed or Refractory Multiple Myeloma (RRMM)

被引：1
|
作者：
Berenson, James R.
Silagan, Noemi
To, Jennifer
Spektor, Tanya M.
Martinez, Daisy
Sanchez, Armando J.
Forouzan, Eli
Swift, Regina
Eades, Benjamin
Schwartz, Gary
Eshaghian, Shahrooz
Boccia, Ralph V.
Yang, Honghao Hank
Lim, Stephen
Vescio, Robert
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-143005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Efficacy and Safety of Ruxolitinib and Steroids for Treating Patients with Relapsed or Refractory Multiple Myeloma
    Berenson, James R.
    Martinez, Daisy
    Safaie, Tahmineh
    Silagan, Noemi
    To, Jennifer
    Spektor, Tanya M.
    Forouzan, Eli
    Swift, Regina
    Eades, Benjamin
    Eshaghian, Shahrooz
    Schwartz, Gary
    Boccia, Ralph V.
    Yang, Honghao H.
    Moezi, Mehdi M.
    Lim, Stephen
    Vescio, Robert
    [J]. BLOOD, 2021, 138
  • [2] Safety and Efficacy of the Combination of Selinexor, Lenalidomide and Dexamethasone (SRd) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
    White, Darrell
    LeBlanc, Richard
    Venner, Chritopher
    Bahlis, Nizar J.
    Lentzsch, Suzanne
    Gasparetto, Cristina J.
    Chen, Christine
    Lipe, Brea
    Sutherland, Heather
    Tuchman, Sascha
    Baljevic, Muhamed
    Kotb, Rami
    Sebag, Michael
    Callander, Nancy
    Bensinger, William
    Kai, Kazuharu
    Liu, Jianjun
    Sheehan, Heidi
    Estepan, Daniel Nova
    Shah, Jatin
    Schiller, Gary J.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E55 - E55
  • [3] A phase 1 study of ruxolitinib, steroids and lenalidomide for relapsed/refractory multiple myeloma patients
    Berenson, James R.
    Kim, Clara
    Bujarski, Sean
    To, Jennifer
    Spektor, Tanya M.
    Martinez, Daisy
    Turner, Carley
    Ghermezi, Matthew
    Eades, Benjamin M.
    Swift, Regina A.
    Schwartz, Gary
    Eshaghian, Shahrooz
    Moss, Robert A.
    Lim, Stephen
    Vescio, Robert
    [J]. HEMATOLOGICAL ONCOLOGY, 2022, 40 (05) : 906 - 913
  • [4] A Phase I Study of Ruxolitinib, Lenalidomide, and Steroids for Patients with Relapsed/Refractory Multiple Myeloma
    Berenson, James R.
    To, Jennifer
    Spektor, Tanya M.
    Martinez, Daisy
    Turner, Carley
    Sanchez, Armando
    Ghermezi, Matthew
    Eades, Benjamin M.
    Swift, Regina A.
    Schwartz, Gary
    Eshaghian, Shahrooz
    Stampleman, Laura
    Moss, Robert A.
    Lim, Stephen
    Vescio, Robert
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (10) : 2346 - 2353
  • [5] Efficacy and Safety of Elranatamab in Black Patients with Relapsed/Refractory Multiple Myeloma (RRMM): A Subgroup Analysis of the Magnetismm Studies
    Varshavsky-Yanovsky, Asya
    Jethava, Yogesh
    Stevens, Don A.
    Nooka, Ajay K.
    Stiff, Patrick J.
    Perez-Cruz, Isabel
    Leip, Eric
    Lesokhin, Alexander
    [J]. BLOOD, 2023, 142
  • [6] Selinexor for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
    Anum, Babar
    Hina, Zubair
    Mainoma, Bano
    Sana, Rafique
    Arzu, Shahid
    Maham, Babar
    Waleed, Madeeha S.
    Arslan, Inayat
    Danish, Safi
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 : S29 - S29
  • [7] Therapy of relapsed and/or refractory multiple myeloma (RRMM)
    Engelhardt, M.
    Waesch, R.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 14 - 14
  • [8] Efficacy and safety of elranatamab in Japanese patients with relapsed/refractory multiple myeloma (RRMM): a pooled analysis from the MagnetisMM studies
    Ishida, Tadao
    Yokoyama, Hisayuki
    Suzuki, Kenshi
    Ito, Satoshi
    Nagai, Yuya
    Handa, Hiroshi
    Ito, Shigeki
    Kamei, Yoichi
    Nakamura, Masatoshi
    Viqueira, Andrea
    White, Jane Liang
    Take, Kazumi
    Moribe, Toyoki
    Iida, Shinsuke
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S186 - S187
  • [9] Ruxolitinib and Methylprednisolone for Treatment of Patients with Relapsed/Refractory Multiple Myeloma
    Berenson, James R.
    Martinez, Daisy
    Safaie, Tahmineh
    Boccia, Ralph
    Yang, Honghao H.
    Moezi, Mehdi M.
    Lim, Stephen
    Schwartz, Gary Edward
    Eshaghian, Shahrooz
    Swift, Regina
    Eades, Benjamin
    Bujarski, Sean Elliott
    Regidor, Bernard Sean
    Kim, Clara
    Kim, Susanna
    Vescio, Robert
    [J]. BLOOD, 2022, 140 : 12610 - 12611
  • [10] Ruxolitinib and methylprednisolone for treatment of patients with relapsed/refractory multiple myeloma
    Berenson, James R. R.
    Martinez, Daisy
    Safaie, Tahmineh
    Boccia, Ralph
    Yang, Honghao
    Moezi, Mehdi
    Lim, Stephen
    Schwartz, Gary
    Eshaghian, Shahrooz
    Swift, Regina
    Eades, Benjamin M. M.
    Bujarski, Sean
    Regidor, Bernard
    Kim, Clara
    Kim, Susanna
    Vescio, Robert
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2023, 200 (06) : 722 - 730
12345